Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Careful dosing and monitoring are crucial to prevent adrenal insufficiency when using ketoconazole for Cushing's disease.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Hydroxychloroquine may help COVID-19 patients with lupus.

The treatment was effective for lupus nephritis with manageable side effects.

These medications for BPH have known risks and may have new side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Apremilast showed mixed results for treating severe alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Sertraline can cause hair loss, which stops after stopping the drug.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.